Cleared Traditional

K841452 - NOVA STAT CONTROL LEVELS 1/2/3

K841452 is the FDA 510(k) clearance for NOVA STAT CONTROL LEVELS 1/2/3 by Nova Biomedical Corp.. It is a Class 1 Chemistry device (product code JJY) cleared through the Traditional 510(k) pathway after a 74-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1984
Decision
74d
Days
Class 1
Risk

K841452 is an FDA 510(k) clearance for the NOVA STAT CONTROL LEVELS 1/2/3. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Nova Biomedical Corp. (Mchenry, US). The FDA issued a Cleared decision on June 22, 1984 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nova Biomedical Corp. devices

Submission Details

510(k) Number K841452 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 1984
Decision Date June 22, 1984
Days to Decision 74 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 88d · This submission: 74d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 369
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K841452.
LYPHOCHEK PREGNANCY CONTROL SERUM HUMAN
K844125 · Bio-Rad · Jan 1985
QUALIFY I & II AMER. MONITOR 2009 & 2010
K843611 · American Monitor Corp. · Sep 1984
KODAK EKTACHEM CONTROL
K841884 · Eastman Kodak Company · Jul 1984
BIOTIS ABNORMAL CLINICAL CHEM SERUM-
K840458 · Otisville Biotech, Inc. · Apr 1984
NORMAL CLINICAL CHEM. CONTROL SERUM-
K840457 · Otisville Biotech, Inc. · Apr 1984
ORTHO BI-LEVEL RECEPTOR CONTROL
K834064 · Ortho Diagnostic Systems, Inc. · Mar 1984